HAAD-accredited MRCP study in Abu Dhabi
May 9-11 2013
www.icldc.co.uk
Abu Dhabi, UAE 11 March 2013: The Arabian Gulf's young doctors can now study in Abu Dhabi for the sought-after Membership of the Royal Colleges of Physicians (MRCP).
MRCP Part 1 and Part 2 will take place from May 9-11 at the Imperial College London Diabetes Centre (ICLDC), the state-of-the art diabetes treatment centre in Abu Dhabi.
Recent MRCP courses held at the UAE capital's ICLDC, in partnership with UK's Hammersmith Medicine, have won positive delegate feedback for high quality content and instruction. ICLDC has a purpose-designed lecture theatre, interaction areas and offers easy access to a number of hotels and airport.
According to the course leader, Imperial College London's Professor Karim Meeran the vigorous programmes provide outstanding preparation and are an ideal stepping stone for the MRCP examination.
"Passing the MRCP is a tough proposition for young doctors yet it's compulsory if they have aspirations to become a specialist. These courses are designed to ease the pressure and ensure candidates have the best possible chance.
"We have considered the sort of questions that will come up and we coach doctors in a way that will make them better prepared to pass with flying colours."
Professor Meeran added that due to the region's growing demand for doctors, it makes sense to hold the courses in the UAE. Recent courses have had an international flavour with participants from Canada and the UK, as well as from the region with the likes of Oman, Qatar and Kuwait represented.
Due to growing demand, the training course has been expanded and is set to be held at ICLDC three times this year.
"Both the MRCP 1 and 2 programme are continuously reviewed by the Health Authority Abu Dhabi and accredited for 21.5 and 22 CME hours respectively," added Professor Meeran.
Registration can be made online at www.icldc.co.uk or at cme@icldc.ae or Tel: + 971 2 404 0870
About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness, with two centres - one each in Abu Dhabi and Al Ain.
The purpose-built centres are an initiative of Mubadala Healthcare, in partnership with the UK's Imperial College London. Mubadala Healthcare, a division of Mubadala Development Company, is specifically dedicated to investment in strategic, high value and economically sustainable projects that meaningfully enhance the private healthcare infrastructure of Abu Dhabi and the UAE.
The launch of ICLDC in 2006 is testament to the vision of Mubadala Healthcare to develop projects that protect and enhance the nation's health. ICLDC has offered diabetes prevention, education and treatment to more than 160,000 people.
'Diabetes-Knowledge-Action' is ICLDC's award-winning public health awareness campaign. It was launched in 2007 under the patronage of Her Highness Sheikha Fatima bint Mubarak.
ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care. When the Centre in Abu Dhabi received the awards it became the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI's highly-acclaimed CCPC specifically for the clinical management of diabetes.
For more information log on to www.icldc.ae
For media enquiries:
Susan Furness at Strategic Solutions for ICLDC
Tel.: + 9714 3903030,
Mobile: + 97150 6556126
Email: susan@strategicsolutionsonline.com
© Press Release 2013
